Gynecologic Oncology

Gynecol Oncol · ISSN (print) 0090-8258 · ISSN (e) 1095-6859 · 339 papers in corpus
review 1998
doi:10.1006/gyno.1998.4953 ·PMID:9570997

We present 4 cases of endometriosis complicated by massive ascites from our institution and a review of 27 cases from the literature. In most of these patients, the presence of ascites with its related symptoms in association with pelvic ma…

case-report 1998
doi:10.1006/gyno.1998.5139 ·PMID:9784337

BACKGROUND: In patients with endometrial carcinoma, the use of hysteroscopy may result in malignant peritoneal cytology. The significance of these mechanically disseminated malignant cells is uncertain. CASE: Disseminated endometrial carci…

case-report 1998
doi:10.1006/gyno.1998.4952 ·PMID:9570985

Cutaneous endometriosis infrequently arises in the absence of pelvic disease. Rare features such as myxoid change can resemble malignancy and may pose a challenging histological diagnosis. We are not aware of any previous cases involving no…

case-report 1998
doi:10.1006/gyno.1998.5048 ·PMID:9740709

A case of a yolk sac tumor (YST) with an ovarian endometrioid adenocarcinoma arising from endometriosis in a postmenopausal woman is described. Clinically, the case showed an aggressive course and did not respond to chemotherapy; the patien…

case-report 1998
doi:10.1006/gyno.1998.5058 ·PMID:9790801

In contrast to the strong association between human papillomavirus (HPV) and cervical intraepithelial neoplasia (CIN), the relationship between HPV and squamous epithelial lesions of the ovary is less clear. We report a case of synchronous …

other 1997
doi:10.1006/gyno.1997.4620 ·PMID:9159340

The single most common cause leading to the diagnosis of endometrial cancer is postmenopausal bleeding. Although most patients with early-stage disease (FIGO stage I and II) can be cured, prognosis worsens considerably with increasing stage…

other 1996
doi:10.1006/gyno.1996.0065 ·PMID:8774649

Between 1982 and 1992, 24 women with Stage III clear cell ovarian cancer were identified from the tumor registry. Thirty-four women with Stage III papillary serous tumors treated between 1987 and 1989 were used as a comparison. All patients…

case-report 1996
doi:10.1006/gyno.1996.0235 ·PMID:8751569

A case of endometriosis with myxoid change is presented here which raised concern for metastatic adenocarcinoma and pseudomyxoma peritonei. This is the second case similar to the one described previously in the literature. A 51-year-old wom…

observational 1996
doi:10.1006/gyno.1996.0032 ·PMID:8631545

Between 1975 and 1990, 79 patients with Stage I epithelial ovarian cancer were treated at Massachusetts General Hospital. Patients were identified from the tumor registry and medical records were retrospectively reviewed. Pathological slide…

other 1996
·PMID:8626109
observational 1996
doi:10.1006/gyno.1996.0222 ·PMID:8751556

Histopathologic changes ranging from simple cystic hyperplasia to carcinoma in situ may be observed in adenomyotic foci in patients with endometrial carcinoma. These changes can be an area of concern and physicians should be aware of their …

other 1996
·PMID:8631563
case-report 1996
doi:10.1006/gyno.1996.0233 ·PMID:8751567

The complete clinical course of a case of ovarian clear cell carcinoma expressing luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor arising from endometriosis in a pregnant woman is presented. A 31-year-old woman visited …

observational 1995
doi:10.1006/gyno.1995.1243 ·PMID:7672702

We examined peripheral blood T-lymphocyte subsets before initiation of therapy in 79 healthy controls, 3 patients with endometriosis, 95 patients with common epithelial tumors of the ovary, 15 patients with ovarian germ cell tumors, and 3 p…

review 1995
doi:10.1006/gyno.1995.1188 ·PMID:7789896

Between September 1, 1989 and October 31, 1994, 173 postmenopausal breast cancer women on tamoxifen treatment were followed up in the authors' institutions. During this period, 14 (8.1%) underwent total abdominal hysterectomy and bilateral …

observational 1995
doi:10.1006/gyno.1995.1266 ·PMID:7557614

OBJECTIVE: To survey the attitudes of gynecologic oncologists about indications for blood transfusion, and compare them to current recommendations about transfusion practice. METHODS: With the permission of the Society of Gynecologic Oncol…

observational 1995
doi:10.1006/gyno.1995.1271 ·PMID:7557621

In order to better understand the clinical presentation and biologic behavior of ovarian carcinomas arising in endometriosis, we performed a historical cohort study of all women with endometrioid adenocarcinoma of the ovary (ECO) diagnosed …

other 1995
doi:10.1006/gyno.1995.1228 ·PMID:7622122
review 1995
doi:10.1006/gyno.1995.9950 ·PMID:8522267

Müllerian adenosarcomas of the uterus usually present as pedunculated endometrial masses in postmenopausal women with vaginal bleeding. Extraendometrial variants (originating in the ovary, adnexa, or myometrium) are much less common, and th…

other 1994
doi:10.1006/gyno.1994.1214 ·PMID:8088606

Thirty-nine cases of endometrial carcinoma were analyzed by magnetic resonance imaging (0.15 or 1.5 tesla (T) MRI) prior to surgery to evaluate the depth of myometrial invasion of endometrial carcinoma. Several diagnostic parameters of MRI …

review 1994
doi:10.1006/gyno.1994.1151 ·PMID:8206414

We describe a rare case of extrauterine adenosarcoma, the first arising in the Pouch of Douglas, in a 49-year-old premenopausal woman with an elevated CA 125. The tumor consisted of benign glandular and malignant stromal elements. There was…

review 1994
doi:10.1006/gyno.1994.1342 ·PMID:7835812

The distinct pathologic and biologic nature of ovarian tumors of low malignant potential (LMP) has been officially recognized by FIGO and the World Health Organization. LMP tumors may comprise 10% of ovarian neoplasms; they occur at a mean …

case-report 1994
doi:10.1006/gyno.1994.1319 ·PMID:7835785

We present the first case of ovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer. The association with prolonged unopposed estrogen-like stimulation with tamoxifen as…

lab-animal 1994
doi:10.1006/gyno.1994.1264 ·PMID:7959256

In support of a possible clinical use of gonadotropin-releasing hormone (Gn-RH) analogs in the treatment of the endometrial carcinoma, this study was undertaken to establish the presence and characteristics of Gn-RH receptor on endometrial …

observational 1994
doi:10.1006/gyno.1994.1158 ·PMID:8020830

Ninety-three consecutive operative cases of myometrial invasive endometrioid adenocarcinoma of the uterus without evidence of extrauterine spread at surgery were reviewed to determine whether any histopathologic features other than those tr…